Faeth Therapeutics, Inc. (FTH) vs Mesa Laboratories, Inc. (MLAB)
A side-by-side comparison of Faeth Therapeutics, Inc. and Mesa Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FTH
Faeth Therapeutics, Inc.
$27.67HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
MLAB
Mesa Laboratories, Inc.
$136.72HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — FTH vs MLAB
growth of $100 · dividends reinvested · last 6yFTH -92.8% (-35.5%/yr)MLAB -47.4% (-10.1%/yr)MLAB compounded faster over this window
Log scale — wide-divergence pair
FTH MLAB
FTH vs MLAB: by the numbers
- •MLAB is the larger company ($765M vs $713M market cap).
- •MLAB is profitable (1.92% net margin) while FTH runs a net loss (0.00%).
- •MLAB pays a dividend (0.45% yield), while FTH has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | FTH | MLAB |
|---|---|---|
| P/E ratio | N/A | 162.76 |
| PEG ratio | N/A | 11.98 |
| P/S ratio | N/A | 3.06 |
| P/B ratio | 4.12 | 4.05 |
| EV / EBITDA | N/A | 18.39 |
| FCF yield | N/A | 6.91% |
Profitability
| Metric | FTH | MLAB |
|---|---|---|
| Gross margin | 0.00% | 65.99% |
| Operating margin | 0.00% | 9.00% |
| Net margin | 0.00% | 1.92% |
| ROE | -113.05% | 2.54% |
| ROIC | -110.62% | 3.29% |
Dividends
| Metric | FTH | MLAB |
|---|---|---|
| Dividend yield | N/A | 0.45% |
| Payout ratio | N/A | 76.19% |
Growth (annualized)
| Metric | FTH | MLAB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.45% |
| EPS CAGR (5Y) | N/A | 13.08% |
| FCF CAGR (5Y) | N/A | 4.63% |
| Total return CAGR (5Y) | -31.75% | -13.52% |
Frequently asked
- Does FTH or MLAB pay a bigger dividend?
- MLAB pays a dividend (0.45% yield), while FTH has no payments in the available dividend history.
- Is FTH or MLAB more profitable?
- MLAB runs the higher net margin — FTH at 0.00% versus MLAB at 1.92%.
- How have FTH and MLAB total returns compared?
- Over the past 5 years, FTH delivered -31.75% and MLAB delivered -13.52% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Mesa Laboratories P/E ratioMesa Laboratories dividend yieldFaeth Therapeutics ROEMesa Laboratories ROEFaeth Therapeutics operating marginMesa Laboratories operating marginFaeth Therapeutics revenue growthMesa Laboratories revenue growthFaeth Therapeutics free cash flowMesa Laboratories free cash flow
Faeth Therapeutics & Mesa Laboratories appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.